Barlattani, Angelo

Publishing since 2008 (Baby)

Has published 4 publications in 3 years

Number of publications published per year by Barlattani, Angelo. (Source : PubMed)

Distribution of publications types for Barlattani, Angelo. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

Mecenate F, Pellicelli AM, Barbaro G, Romano M, Barlattani A, Mazzoni E, Bonaventura ME, Nosotti L, Arcuri P, Picardi A, Barbarini G, D'Ambrosio C, Paffetti A, Andreoli A, Soccorsi F. Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial. BMC Gastroenterol 2010;10
Puoti C, Pellicelli AM, Romano M, Mecenate F, Guarisco R, Barbarini G, Mazzoni E, Spilabotti L, Bellis L, Paglia F, Barlattani A, Picardi A, Paffetti A, Bonaventura ME, Nosotti L, Mitidieri O, Dell'Unto O, Villani R, Dell'Unto C, Morrone A, Soccorsi F. Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon alpha-2a and ribavirin: a multicentric study. Liver Int. 2009;29;10
Angelico M, Koehler-Horst B, Piccolo P, Angelico F, Gentile S, Francioso S, Tarquini P, Vecchia RD, Ponti L, Pilleri G, Barlattani A, Grieco A, Soccorsi F, Guarascio P, Demelia L, Sorbello O, Rossi Z, Forlini G, Zaru S, Bandiera F. Peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a monotherapy in early virological responders and peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a, ribavirin and amantadine triple therapy in early virological nonresponders: the SMIEC II trial in naïve patients with chronic hepatitis C. Eur J Gastroenterol Hepatol 2008;20;7
Pellicelli AM, Barbaro G, Francavilla R, Romano M, Barbarini G, Mazzoni E, Mecenate F, Paffetti A, Barlattani A, Struglia C, Villani R, Nauri L, Nosotti L, Armignacco O, Ferri F, Camporiondo MP, Soccorsi F. Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study. Clin Ther 2008;30;2

[ See timeline ] [ See all publications ]

h=5

means that Barlattani, Angelo has 5 papers cited a least 5 times - methodology

Key figures

4 pub in 3 years
1.3 publications/year
best year 2008 with 2 pub
h-index 5 with 4 pub
h-ratio : 125 %

See Timeline

Ranking

It's me !

Click here if you are
Barlattani, Angelo.

Most frequent Journals

Clin Ter (6x)
Aliment. Pharmacol. Ther. (2x)
Liver Int. (1x)
BMC Gastroenterol (1x)
Eur J Gastroenterol Hepatol (1x)

Main affiliation

Liver Unit San Camillo Forlanini Hospital, Rome, Italy.

Latest co-workers

Barbarini G Barbaro G Bonaventura ME Camporiondo MP D'Ambrosio C Ferri F Gentile S Mazzoni E Mecenate F Morrone A Nosotti L Paffetti A Paglia F Pellicelli AM Picardi A Romano M Rossi Z Soccorsi F Sorbello O Villani R

Back to HepaTop

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.